5HSIA T C, SHEN Y Y, YEN R F, et al. Comparing whole body ^18 F-2-deoxyglueose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer [J]. Neoplasma, 2002,49(4) :267-271.
6UEMATSU T, YUEN S, YUKISAWA S, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer [J]. A JR, 2005,184(4) : 1266-1273.
7YANG S N, LIANG J A, LIN F J, et al. Comparing whole body (18)F-2-deoxyglucose positronemission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer[J]. J Cancer Res Clin Oncol, 2002, 128(6): 325-328.
8GARCIA J R, SIMO M, PEREZ G, et al. ^99mTc-MDP bone scintigraphy and ^18 F-FDG positron emission tomography in lung and prostate cancer patients., different affinity between lytic and sclerotic bone metastases[J]. Eur J Nucl Med Mol Imaging, 2003,30 (12) : 1714.
9KATO H, MIYAZAKI T, NAKAJIMA M, et al. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas[J]. AnticancerRes, 2005,25(6C) :4439-4444.
10AYDIN A, YU J Q, ZHUANG H, et al. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma[J]. Clin Nucl Med, 2005,30 (9) :606-607.
4Castillo M,Arbelaez A,Smith JK,et al.Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases[J].AJNR,2000,21(5):948-953.
5Chen WT,Shih TT,Chen RC,et al.Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI:in comparison with compression fracture and metastasis[J].J Magn Reson Imaging,2002,15(3):308-314.
6Ryan PJ,Fogelman I.The bone scan:where are we now[J]? Semin Nucl Med,1995,25(2):76-91.
7Peterson JJ,Kransdorf MJ,O'Connor MI.Diagnosis of occult bone metastases:positron emission tomography[J].Clin Orthop,2003,415(10):120-128.
8Cook GJ,Houston S,Rubens R,et al.Detection of bone metastases in breast cancer by 18-FDG PET:Differing metabolic activity in osterblastic and osteolytic lesions[J].J Clin Oncol,1998,16(10):3375-3379.
9Bury T,Barreto A,Daenen F,et al.Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer[J].Eur J Nucl Med,1998,25(9):1244-1247.
10Zoeller G,Sandrock D,Munz DI,et al.Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies[J].Eur Urol,1994,26(2):141-144.
4Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. BMC Med Res Methodol, 2003, 3.-25.
5Ohta,M,Tokuda Y,Suzuki Y,et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone seintigraphy [J]. Nucl Med Commun,2001,22(8) : 875 - 879.
6Nakai T,Okuyama C, Kubota T, et al. Pitfalls of FDG- PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer[J]. Eur J Nucl Med Mol Imaging ,2005 ,32( l l ) :1253 - 1258.
7Abe K, Sasaki M, Kuwabara Y, et al. Comparison of 18FDG-PET with Tc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer[J]. Ann Nucl IVied ,2005,19(7) : 573 - 579.
8Gallowitsch HJ, Kresnik E, Gasser J, et al. F 18 Fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma=a comparison to conventional imaging[J]. Invest Radiol, 2003,38 (5) : 250 - 256.
9Uematsu T, Yuen S, Yukisawa S, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer[J]. A JR Am J Roentgenol, 2005,184 : 1266 - 1273.
10Yang,SN,Liang JA,Lin FJ,et al. Comparing whole body ^18F-2-deoxyglueose positron emission tomography and technetium 99m methylene diphosphonate bone scan to detect bone metastases in patients with breast eaneer[J]. J Cancer Res Clin 0ncol,2002,128(6) :325 - 328.
